Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2021-12-17 2021-11-18
Drug Identification Number 02416662 02416662
Brand name TEVA-ABACAVIR/LAMIVUDINE TEVA-ABACAVIR/LAMIVUDINE
Common or Proper name ABACAVIR/LAMIVUDINE 600/300MG TAB ABACAVIR/LAMIVUDINE 600/300MG TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients LAMIVUDINE ABACAVIR LAMIVUDINE ABACAVIR
Strength(s) 300MG 600MG 300MG 600MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 30 30
ATC code J05AR J05AR
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2021-10-20 2021-10-20
Estimated end date 2021-12-31 2021-12-31
Actual end date 2021-12-14
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Short dated lots Short dated lots
Health Canada comments